Legal Status of Peptides in Romania (2026)
Research peptides are legal to purchase in Romania for scientific investigation. The Romanian Health Reform Law (Legea nr. 95/2006) and the accompanying Order of the Ministry of Health define medicinal products by their intended use — compounds sold strictly for laboratory research are not subject to the prescription regime that applies to registered medicines.
The National Agency for Medicines and Medical Devices of Romania (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale din Romania — ANMDMR) regulates marketed pharmaceuticals. Research peptides such as BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Glutathione, and NAD+ are not listed as controlled substances under Romanian or EU drug legislation.
ANMDMR Compliance Points
ORYN operates within the Romanian research-chemical framework by maintaining strict research-use labelling, providing a Certificate of Analysis for every batch, and never marketing any peptide with therapeutic or dosing claims for humans. All products are manufactured in GMP-certified facilities in South Korea and independently tested at >99% purity by HPLC and LC-MS.
Compliance checklist: - Research-only labelling on every pen and carton - No medical, therapeutic, or self-administration guidance provided - COA attached to every shipment - Intra-EU dispatch from the Netherlands — no Romanian customs inspection
AVAILABLE PEPTIDE PENS
Delivery to Romania — 3–5 business days
ORYN delivers peptide pens across Romania in 3–5 business days through FAN Courier and Sameday. Major metros — Bucharest (Bucuresti), Cluj-Napoca, Timisoara, Iasi, Constanta, Craiova, Brasov — are reached in 3 business days; transit to smaller towns in Moldova and Dobrogea regions takes an additional 1–2 days.
Delivery details: - Free shipping on orders above EUR 175 - Temperature-controlled insulated box with gel packs - Outer packaging plain, no product descriptors - Tracked from Amsterdam dispatch hub to Romanian doorstep